JP7820832B2 - 抗菌性及び抗ウイルス性硫黄含有グリセロールモノエステル誘導体 - Google Patents

抗菌性及び抗ウイルス性硫黄含有グリセロールモノエステル誘導体

Info

Publication number
JP7820832B2
JP7820832B2 JP2023518450A JP2023518450A JP7820832B2 JP 7820832 B2 JP7820832 B2 JP 7820832B2 JP 2023518450 A JP2023518450 A JP 2023518450A JP 2023518450 A JP2023518450 A JP 2023518450A JP 7820832 B2 JP7820832 B2 JP 7820832B2
Authority
JP
Japan
Prior art keywords
day
compound
compounds
alkyl
present disclosure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023518450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543442A5 (https=
JP2023543442A (ja
Inventor
ティ． リアダン、デイトン
ブレナン、ポール
シュリーバート、パトリック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niche Biopharmaceuticals LLC
Original Assignee
Niche Biopharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niche Biopharmaceuticals LLC filed Critical Niche Biopharmaceuticals LLC
Publication of JP2023543442A publication Critical patent/JP2023543442A/ja
Publication of JP2023543442A5 publication Critical patent/JP2023543442A5/ja
Application granted granted Critical
Publication of JP7820832B2 publication Critical patent/JP7820832B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/02—Monothiocarboxylic acids
    • C07C327/04—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/06—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/36—Esters of dithiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2023518450A 2020-09-18 2021-09-17 抗菌性及び抗ウイルス性硫黄含有グリセロールモノエステル誘導体 Active JP7820832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/948,453 2020-09-18
US16/948,453 US11572342B2 (en) 2020-09-18 2020-09-18 Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
PCT/US2021/071500 WO2022061365A1 (en) 2020-09-18 2021-09-17 Antimicrobial and antiviral sulfur containing glycerol monoester derivatives

Publications (3)

Publication Number Publication Date
JP2023543442A JP2023543442A (ja) 2023-10-16
JP2023543442A5 JP2023543442A5 (https=) 2024-09-26
JP7820832B2 true JP7820832B2 (ja) 2026-02-26

Family

ID=80739431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518450A Active JP7820832B2 (ja) 2020-09-18 2021-09-17 抗菌性及び抗ウイルス性硫黄含有グリセロールモノエステル誘導体

Country Status (5)

Country Link
US (3) US11572342B2 (https=)
EP (1) EP4214191A4 (https=)
JP (1) JP7820832B2 (https=)
CN (1) CN116323556B (https=)
WO (1) WO2022061365A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11572342B2 (en) 2020-09-18 2023-02-07 Niche Biopharmaceuticals LLC Antimicrobial and antiviral sulfur containing glycerol monoester derivatives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530622A (ja) 2005-02-17 2008-08-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 光導波路
JP2008533048A (ja) 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
JP2015514782A (ja) 2012-04-20 2015-05-21 ヘネピン ライフ サイエンシーズ 微生物感染症の局所的治療のための組成物
WO2019079150A1 (en) 2017-10-18 2019-04-25 Hennepin Life Sciences, Llc COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208257A (en) 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US4746515A (en) 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5256405A (en) 1991-12-30 1993-10-26 Tom's Of Maine Herbal deodorant
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5569461A (en) 1995-02-07 1996-10-29 Minnesota Mining And Manufacturing Company Topical antimicrobial composition and method
US5906814A (en) 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
DE69739583D1 (de) 1996-11-14 2009-10-29 Lipomedica Ehf Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
BR112012006107A2 (pt) 2009-09-17 2016-06-07 Eugene B Guthery formulações nasais, de ferida e de pele e métodos para controle de staphylococci e outras bactérias gram-positivas resistentes a antibiótico
US11572342B2 (en) * 2020-09-18 2023-02-07 Niche Biopharmaceuticals LLC Antimicrobial and antiviral sulfur containing glycerol monoester derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530622A (ja) 2005-02-17 2008-08-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 光導波路
JP2008533048A (ja) 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
JP2015514782A (ja) 2012-04-20 2015-05-21 ヘネピン ライフ サイエンシーズ 微生物感染症の局所的治療のための組成物
WO2019079150A1 (en) 2017-10-18 2019-04-25 Hennepin Life Sciences, Llc COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
REGISTRY（STN）[online]，Entered STN: 10 June 2008，[検索日2025.06.26 ]，CAS登録番号1026972-92-8
REGISTRY（STN）[online]，Entered STN: 16 Dec 2015，[検索日2025.06.26 ]，CAS登録番号1823920-05-3

Also Published As

Publication number Publication date
US11873272B2 (en) 2024-01-16
EP4214191A4 (en) 2024-10-30
WO2022061365A1 (en) 2022-03-24
US11365176B2 (en) 2022-06-21
JP2023543442A (ja) 2023-10-16
US11572342B2 (en) 2023-02-07
CN116323556B (zh) 2026-04-03
CN116323556A (zh) 2023-06-23
EP4214191A1 (en) 2023-07-26
US20230174473A1 (en) 2023-06-08
US20220127224A1 (en) 2022-04-28
US20220089535A1 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
US20240285598A1 (en) Compounds for the treatment of sars
US11795159B2 (en) Compounds for the treatment of SARS
CN107922404A (zh) 氯喹和克立咪唑化合物用于治疗炎症和癌症的用途
KR20230005240A (ko) Sars 치료를 위한 화합물
KR20230012528A (ko) Sars 치료를 위한 화합물
US20240043417A1 (en) Compounds for the treatment of sars
US20240408062A1 (en) Compounds for the treatment of sars
JP7820832B2 (ja) 抗菌性及び抗ウイルス性硫黄含有グリセロールモノエステル誘導体
KR102893040B1 (ko) 독성이 감소된 혼성 암포테리신 b 유도체
AU2016205187A1 (en) Concise synthesis of urea derivatives of amphotericin B
CN116178373A (zh) 非甾体抗炎药和gs-441524的二联体化合物及其制备方法与用途
US20240409510A1 (en) Compounds for the treatment of sars
WO2022119854A1 (en) Compounds for the treatment of sars
JP7711088B2 (ja) Ｓａｒｓの治療のための化合物
US20240101541A1 (en) Compounds for the treatment of sars
US20240287108A1 (en) nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES
WO2023242070A1 (en) Antimicrobial compounds
BR122023026497A2 (pt) Uso de um composto e método para produzir um composto
JP2004292366A (ja) １，２−ジオキサン化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240917

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241025

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260205

R150 Certificate of patent or registration of utility model

Ref document number: 7820832

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150